Yelin Lapidot Holdings Management Ltd. Harmony Biosciences Holdings, Inc. Transaction History
Yelin Lapidot Holdings Management Ltd.
- $607 Billion
- Q3 2024
A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 37,905 shares of HRMY stock, worth $1.3 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
37,905
Previous 37,905
-0.0%
Holding current value
$1.3 Million
Previous $1.14 Billion
32.58%
% of portfolio
0.25%
Previous 0.2%
Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
231Shares Held
45.1MCall Options Held
48.2KPut Options Held
56.5K-
Valor Management LLC Chicago, IL11.2MShares$385 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$200 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$121 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$89.4 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$86.1 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.03B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...